HealthVerity

HealthVerity builds its ecosystem by contracting directly with data owners — payers, laboratories, electronic health record systems, and consumer data partners — who contribute de-identified records into the Marketplace. The company does not resell raw datasets; instead, it links records through its Identity Manager engine and provides governed analytics access to clients under its IPGE framework.

Acquired in early 2025, Symphony Health brought deep commercial analytics assets that had long been used by pharma for prescriber and claims analysis. The deal united those assets with HealthVerity’s clinical data ecosystem, giving users a single environment to explore clinical and commercial patterns together. It broadened the company’s addressable base among top-20 pharmaceutical firms.

Life sciences organizations form the core client base, including the majority of the top U.S. pharmaceutical and biotechnology companies. HealthVerity also serves health insurers for risk adjustment and underwriting, government agencies for program oversight, and media and channel partners that need deterministic healthcare audiences for measurement campaigns.

All patient records within the ecosystem are de-identified before ingestion, and the Identity Manager performs HIPAA-compliant matching without re-identifying individuals. The IPGE governance layer enforces data-use permissions so that each customer only accesses the records they are contractually allowed to query. This architecture allows analytics on linked records while data stays within the governed environment.

HealthVerity is a privately held technology company and does not publicly disclose funding rounds, valuation, or a path to external investment. There is no known vehicle through which a family office or institutional allocator can participate directly.